Source: drugtargetreview.com Advances in next generation sequencing mean we are now enjoying the era of the sub-1000-dollar genome, and the world’s genomic databases are expanding exponentially with primary sequence data from more and more individuals daily. These terabytes of genomic data, alongside the growing wealth of digital health records and clinical trials, bring invaluable insights Read More